breast cancer - triple negative | ||
mBC - Triple negative (TNBC) - 1st Line (L1) | es-BC - TNBC - NA - all population | |
non platinum-based chemotherapy | ||
taxanes | ||
paclitaxel | ||
nab-paclitaxel | TORCHLIGHT TORCHLIGHT | |
paclitaxel followed by doxorubicin plus cyclophosphamide | ALEXANDRA/IMpassion-030 |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -